1628. Advances in CMV Vaccines
Session: Symposium: Vaccines Against Herpesviruses
Friday, October 5, 2018: 2:50 PM
Room: S 305-314
Mark R. Schleiss, MD, Department of Pediatrics, University of Minnesota Medical School, Falcon Heights, MN; Department of Pediatrics, University of Minnesota, Minneapolis, MN

Dr. Mark R. Schleiss is Professor and American Legion and Auxiliary Heart Research Foundation Endowed Chair of Pediatric Infectious Diseases at the University of Minnesota Medical School. His laboratory has been continuously funded since the early 1990s to conduct research into the pathogenesis and prevention of congenital cytomegalovirus (CMV) infection. He is an internationally recognized expert in CMV vaccines and has pioneered work in a preclinical model, in guinea pig, to study correlates of immunity for the fetus and efficacy of vaccine strategies in prevention of vertical CMV transmission. He also directs a newborn congenital CMV screening program in Minnesota.


Disclosures:

M. R. Schleiss, Merck Vaccines: Consultant , Consulting fee . GSK Vaccines: Consultant , Consulting fee . VBI Vaccines: DSMB , DSMB Consulting Fee .

See more of: Vaccines Against Herpesviruses
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.